You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Continue

News

Getinge is announcing a medical device recall related to Sevoflurane vaporizers for Flow Family Anesthesia systems

Press Release Gothenburg, Sweden on December 7, 2021

Getinge is announcing a medical device recall related to Sevoflurane vaporizers for Flow Family Anesthesia systems

Getinge is announcing a global medical device recall related to specific Sevoflurane vaporizers for Flow Family Anesthesia systems. To date, no patient or operator adverse events have been reported. Getinge has reported to relevant authorities according to applicable regulations and is now informing affected customer about the issue through a field safety notice/recall. The cost for the field action is not material.

The vaporizer is the unit containing anaesthetic agent and is available for the anaesthetic agents Sevoflurane, Desflurane and Isoflurane. This issue is only applicable for specific Vaporizers used for certain types of Sevoflurane, which is used as an inhalational anesthetic for induction and maintenance of general anesthesia.

Getinge has received eight complaints describing the presence of a yellow substance in the vaporizer. This issue has only been observed when using certain types of Sevoflurane. No patient or operator adverse events have been reported in any of these complaints.

Getinge will continue to investigate and will provide an update once the root cause and/or corrective actions are identified. Customers are requested to follow the instructions in the field safety notice/ field correction notice until further communication from Getinge.

This information is released in order to inform users of mentioned Getinge products, according to standard procedure recommended by regulatory authorities.


Media contact:
Anna Appelqvist, Vice President Corporate Communications
Telephone: +46 (0) 734 244 527
E-mail: anna.appelqvist@getinge.com


About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

Files

Share: